New weight-loss medications like semaglutide (Ozempic/Wegovy) or tirzepatide (Mounjaro) promise a lot: less appetite, less weight, more quality of life. But it’s not that simple. Anyone who eats very little – or says they “can’t eat anything at all” – risks more than just hunger cravings. A balanced diet remains essential, even with medical therapy.
Why Eating Is Still Important Despite Medication
Medications like GLP-1 analogs act on the brain’s satiety center and slow gastric emptying. This means: less appetite and feeling full sooner. Sounds good at first – but your body still needs energy and, above all, nutrients. Anyone who eats too little over weeks or months risks losing valuable muscle mass, feeling fatigued, suffering from constipation, nutrient deficiencies, and even a slower metabolism in the long run.
Studies show that when losing weight with GLP-1 medications, up to 40% of the weight lost may come from lean mass – primarily muscle.¹ To prevent this, you need an adequate intake of protein, vitamins, minerals – and ideally regular exercise.
“Not Eating” Is Not the Answer
Food is not the enemy. On the contrary: eating means self-care – and provides the building blocks your body needs every day. Even if you’re not hungry, your diet should not be drastically reduced. A protein-rich diet (e.g., dairy products, legumes, fish, eggs) combined with gentle physical activity helps protect your muscles – which are not only important for strength but also for a healthy metabolism.
A Call for Self-Care
Medication can be a valuable aid – but never the sole solution. For long-term health, you need more than medical support: you need a balanced diet, time to eat, and sometimes outside help. Professional nutrition therapy can help you find individualized solutions – instead of getting lost in extreme dieting or lack of appetite.
Give your body what it needs – even while losing weight. Not because you have to, but because you deserve it.
Sources:
- Brown, A. et al. (2024). Nutrition support whilst on glucagon-like peptide-1 based therapy: Is it necessary? Current Research in Physiology.
- Ryan, D. H. et al. (2023). Practical obesity management with tirzepatide and semaglutide: A position statement from the European Association for the Study of…
- Wharton, S. et al. (2023). Clinical considerations when initiating GLP-1 receptor agonist therapy in patients with obesity.